ALCAM and cancer: The dysregulation of cell migration, adhesion and invasion regulators, such as MCAM/CD146, ALCAM/CD166, CAR/CXADR, EFNA1, LAMA5, CD73/NT5E and integrins, contributes to cancer progression and metastasis (50–55).